Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuan Angel Lu

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
JAMA Network Open|May 29, 2026
Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for CancerChuan Angel Lu, Changchuan Jiang, Andrew Z Wang, et al.
International Journal of General Medicine|June 16, 2025
Therapeutic Effects of Topical Traditional Chinese Medicine on Upper Extremity FracturesWan-Yi Lin, Chuan Angel Lu, Chia-Wei Chang, et al.
Health Affairs Scholar|July 8, 2025
Geographic variation in Medicare Advantage nonemergency medical transportation benefits 2020-2024Chuan Angel Lu, Lesi He, Arthur S Hong, et al.
Gynecologic Oncology|July 1, 2026
Adjunctive sodium-glucose cotransporter 2 (SGLT2) inhibitors with progestins and endometrial cancer risk in benign uterine diseases and hyperplasiaTing-Tai Yen, Chuan Angel Lu, Tina Yi Jin Hsieh, et al.
JAMA Health Forum|July 10, 2026
Primary Care Cost Sharing in Medicare AdvantageChangchuan Jiang, Chuan Angel Lu, Lesi He, et al.
Journal of the National Cancer Institute|January 9, 2026
Growth of zero-premium Medicare Advantage plans in counties with high cancer mortalityChangchuan Jiang, Lesi He, Chuan Angel Lu, et al.
Health Affairs Scholar|September 22, 2025
Zero-premium Medicare Advantage plans: trends in areas with socioeconomic vulnerability and health needsChangchuan Jiang, Lesi He, Chuan Angel Lu, et al.
JCO Oncology Practice|April 23, 2026
Insurance Disparity in Novel Hormonal Therapy Initiation in Patients With Metastatic Hormone-Sensitive Prostate Cancer: Medicare Advantage Versus Traditional MedicareBaqir Jafry, Chuan Angel Lu, Jonathan Ji, et al.
JCO Oncology Practice|December 15, 2025
Rechallenge With an Epidermal Growth Factor Receptor Inhibitor in Metastatic Colorectal Cancer: A Systematic Review and Meta-AnalysisAmy H Huang, Gin Yi Lee, Chuan Angel Lu, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
JAMA Network Open|May 29, 2026
Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for CancerChuan Angel Lu, Changchuan Jiang, Andrew Z Wang, et al.
International Journal of General Medicine|June 16, 2025
Therapeutic Effects of Topical Traditional Chinese Medicine on Upper Extremity FracturesWan-Yi Lin, Chuan Angel Lu, Chia-Wei Chang, et al.
Health Affairs Scholar|July 8, 2025
Geographic variation in Medicare Advantage nonemergency medical transportation benefits 2020-2024Chuan Angel Lu, Lesi He, Arthur S Hong, et al.
Gynecologic Oncology|July 1, 2026
Adjunctive sodium-glucose cotransporter 2 (SGLT2) inhibitors with progestins and endometrial cancer risk in benign uterine diseases and hyperplasiaTing-Tai Yen, Chuan Angel Lu, Tina Yi Jin Hsieh, et al.
JAMA Health Forum|July 10, 2026
Primary Care Cost Sharing in Medicare AdvantageChangchuan Jiang, Chuan Angel Lu, Lesi He, et al.
Journal of the National Cancer Institute|January 9, 2026
Growth of zero-premium Medicare Advantage plans in counties with high cancer mortalityChangchuan Jiang, Lesi He, Chuan Angel Lu, et al.
Health Affairs Scholar|September 22, 2025
Zero-premium Medicare Advantage plans: trends in areas with socioeconomic vulnerability and health needsChangchuan Jiang, Lesi He, Chuan Angel Lu, et al.
JCO Oncology Practice|April 23, 2026
Insurance Disparity in Novel Hormonal Therapy Initiation in Patients With Metastatic Hormone-Sensitive Prostate Cancer: Medicare Advantage Versus Traditional MedicareBaqir Jafry, Chuan Angel Lu, Jonathan Ji, et al.
JCO Oncology Practice|December 15, 2025
Rechallenge With an Epidermal Growth Factor Receptor Inhibitor in Metastatic Colorectal Cancer: A Systematic Review and Meta-AnalysisAmy H Huang, Gin Yi Lee, Chuan Angel Lu, et al.
Pageof 1